{"id":820320,"date":"2025-03-03T06:34:50","date_gmt":"2025-03-03T11:34:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/"},"modified":"2025-03-03T06:34:50","modified_gmt":"2025-03-03T11:34:50","slug":"affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/","title":{"rendered":"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MANNHEIM, Germany, March  03, 2025  (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD) (\u201cAffimed\u201d, or the \u201cCompany\u201d), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Shawn Leland, PharmD, RPh, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 on Tuesday, March 11, 2025 at 2:20 p.m. Eastern Daylight Time.<\/p>\n<p align=\"justify\">A live webcast of the presentation will be accessible on Affimed\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WJrsHPXX7Edt2vbb22Xt0bXwwE61_UfT2wvcqEqvfsmxYNpAWYlJRE84W23Ouv8ru-PR2tUDhuHGVP1OC6B6sMkOUsKq0t1yqK_9ULYpU3sJ58jYOsZ2duMtc5Y36q7_WtPbiXO_o-lQMCsE5ys_KckWDLwKfa2_tITbhosj7VrSYNVMLj1SToXi4j3gRVVRcg4TLyAeFwUit3rh_PqVwn18kOQRkS1iSX88Px_QlLk=\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/<\/u><\/a>. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call.<\/p>\n<p align=\"justify\">For more information on the conference or to schedule a one-on-one meeting with Affimed\u2019s management, please contact your Leerink Partners representative or Alex Fudukidis via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PWh8lqOY9LJ71PxExLOhkBm1t-sqZVpxHg1Mc9MJwPitpzDcMfEmc3Ph5zYiNhFnLBZsIYYgxE64zkZOWSK38kNztcL-XdL1g-PT1Ys8uCg=\" rel=\"nofollow\" target=\"_blank\"><u>a.fudukidis@affimed.com<\/u><\/a> or phone at +1 (917) 436-8102.<\/p>\n<p align=\"justify\">\n        <strong>About Affimed N.V.<\/strong><br \/>\n        <br \/>Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The Company\u2019s innate cell engagers (ICE<sup>\u00ae<\/sup>) enable a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors. ICE<sup>\u00ae\u00a0<\/sup>are generated on the Company\u2019s proprietary ROCK<sup>\u00ae<\/sup>\u00a0platform which predictably generates customized molecules that leverage the power of innate immune cells to destroy tumor cells. A number of ICE<sup>\u00ae<\/sup>\u00a0molecules are in clinical development, being studied as mono- or combination therapy. Headquartered in Mannheim, Germany, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by the bold vision to stop cancer from ever derailing patients\u2019 lives. For more about the Company\u2019s people, pipeline and partners, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oJo3v4mtgDj7oDaAR4r-REnDDmWQuxKfw3fcybvqV8T8XFyp6ni6cfG-TWhPEGRUUigECNG2sNlOxMM9zf9AUUynZ5422MByRN9L8ltk3p5TGYGIOCyVmjAQVDvy56dWvB76D5llPwnyfkqwdxJgFKEuqeJzvoV0A3R2tCL8Vyb6SUQLdNRvIv3s-ea7XbFmrCJBkG2CShMr_H8GN5o936hlO3MHrLG_ZXHA7-BR5r4=\" rel=\"nofollow\" target=\"_blank\"><u>www.affimed.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Alexander Fudukidis<br \/>Director, Head of Investor Relations<br \/>E-Mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PWh8lqOY9LJ71PxExLOhkBm1t-sqZVpxHg1Mc9MJwPjICaAhe5QWbwtb6NCY_GCn50Eghwnw6ElK8bUn1wtcQ-W9_XzIvtfd3jeqXGu6LIc=\" rel=\"nofollow\" target=\"_blank\"><u>a.fudukidis@affimed.com<\/u><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E4FhzlKmiFviX-rGaEkzAc2SWoKJ0Iau76fDs_OYqRk6iVlIW_SpfDpGTSIegwT6F5hOb7qbSd1Hojw5BlgErg==\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a>Tel.: +1 (917) 436-8102<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzgxMWE3NDYtNGI0YS00NWYwLTg5ZjMtYzBlNDg1NGE0Yjc4LTEwMTUzMDc=\/tiny\/Affimed-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MANNHEIM, Germany, March 03, 2025 (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD) (\u201cAffimed\u201d, or the \u201cCompany\u201d), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Shawn Leland, PharmD, RPh, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 on Tuesday, March 11, 2025 at 2:20 p.m. Eastern Daylight Time. A live webcast of the presentation will be accessible on Affimed\u2019s website at https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call. For more information on the conference or to schedule a one-on-one meeting with Affimed\u2019s management, please contact your Leerink Partners representative &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Affimed to Present at the Leerink Partners Global Healthcare Conference 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-820320","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Affimed to Present at the Leerink Partners Global Healthcare Conference 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MANNHEIM, Germany, March 03, 2025 (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD) (\u201cAffimed\u201d, or the \u201cCompany\u201d), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Shawn Leland, PharmD, RPh, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 on Tuesday, March 11, 2025 at 2:20 p.m. Eastern Daylight Time. A live webcast of the presentation will be accessible on Affimed\u2019s website at https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call. For more information on the conference or to schedule a one-on-one meeting with Affimed\u2019s management, please contact your Leerink Partners representative &hellip; Continue reading &quot;Affimed to Present at the Leerink Partners Global Healthcare Conference 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T11:34:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025\",\"datePublished\":\"2025-03-03T11:34:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/\"},\"wordCount\":303,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/\",\"name\":\"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=\",\"datePublished\":\"2025-03-03T11:34:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/","og_locale":"en_US","og_type":"article","og_title":"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025 - Market Newsdesk","og_description":"MANNHEIM, Germany, March 03, 2025 (GLOBE NEWSWIRE) &#8212; Affimed N.V. (Nasdaq: AFMD) (\u201cAffimed\u201d, or the \u201cCompany\u201d), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Shawn Leland, PharmD, RPh, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 on Tuesday, March 11, 2025 at 2:20 p.m. Eastern Daylight Time. A live webcast of the presentation will be accessible on Affimed\u2019s website at https:\/\/www.affimed.com\/investors\/webcasts-and-corporate-presentation\/. A replay of the call will be archived on Affimed\u2019s website for 30 days after the call. For more information on the conference or to schedule a one-on-one meeting with Affimed\u2019s management, please contact your Leerink Partners representative &hellip; Continue reading \"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-03T11:34:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025","datePublished":"2025-03-03T11:34:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/"},"wordCount":303,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/","name":"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=","datePublished":"2025-03-03T11:34:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzQ4OCM2Nzg2NTYwIzIwMDM3MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/affimed-to-present-at-the-leerink-partners-global-healthcare-conference-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Affimed to Present at the Leerink Partners Global Healthcare Conference 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=820320"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820320\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=820320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=820320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=820320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}